Temple Sensor and Brain Blood Flow: What a Sensor on the Temple Can Do

Published on: ⋄6 min read
Author: Valeriia Voronova, Editor at SOD Energy
Illustration exploring the relationship between an optical signal at the temple and blood flow to the brain

Can blood flow to the brain be measured with a small sensor on the temple? The developers of Temple, a device created by entrepreneur Deepinder Goyal’s company, say it can. The gadget tracks a metric called BrainFlow, which, according to two preliminary studies, changed in line with measurements from methods used to assess cerebral circulation.

However, it is not yet known how accurately BrainFlow reflects blood flow specifically in the brain, or whether it can be used to assess health. The early research looks promising, but its findings need independent confirmation.

Despite these limitations, the device has already attracted buyers’ attention. According to Reuters on November 11, 2026, Temple costs around $900. Goyal says orders have come in from more than 62 countries since early November, although these figures have not been independently confirmed. Growing interest in the gadget raises the key question: how reliable are the metrics users are being asked to use to assess brain function?

Why monitor brain blood flow?

Blood flow to the brain is measured to assess whether brain tissue is receiving enough blood, oxygen, and nutrients to function normally. The brain uses about 20% of the oxygen consumed by the body at rest, so disruptions in blood flow can quickly affect its function. Reasons why it may be necessary to measure blood flow to the brain include:

1. Diagnosing vascular problems. Assessing blood flow can help identify disruptions in cerebral circulation, including those associated with stroke and narrowed blood vessels.

2. Monitoring serious conditions. In intensive care, cerebral perfusion metrics are used in cases of traumatic brain injury and other conditions that carry a risk of insufficient blood supply to the brain.

3. Studying cognitive function. Researchers examine how blood flow in specific brain regions changes during tasks, concentration, and mental exertion.

4. Studying neurodegenerative diseases. Changes in cerebral perfusion are investigated in Alzheimer’s disease and other conditions, although these changes alone cannot establish a diagnosis.

5. Studying responses to physical exertion and stress. Researchers analyze how cerebral blood flow responds to changes in blood pressure, breathing, and physical activity.

What the Temple optical sensor measures

Optical pulse tracking is based on photoplethysmography: light interacts with tissue, and the sensor records changes in the signal associated with pulsed blood volume. But where a device is attached does not, by itself, determine where its physiological information comes from. At the temple, skin, subcutaneous tissue, and bone lie between the device and the brain.

It is therefore important to distinguish recording an optical signal from measuring blood flow to the brain. Circulation near the surface of the body also responds to exertion and changes in posture. If signals from the skin and brain change at the same time, the device may be picking up a broader response from the body.

The authors of the Temple study define BrainFlow as a dimensionless index of relative changes in cerebral hemodynamics. It does not show how many milliliters of blood reach the brain each minute. Even if the index reliably tracks a particular physiological response, it still needs to be linked to a specific measurable quantity and a clinical meaning.

What the first BrainFlow studies found

The September preprint using transcranial Doppler ultrasound included 23 healthy adults. For each of the two tests–exercise on a stationary bike and moving from a standing to a lying position–the researchers analyzed data from 20 people.

BrainFlow was compared with blood velocity in the middle cerebral artery. The median within-person correlation of changes was around 0.8 in both tests. In other words, the graphs rose and fell in fairly close alignment. A correlation of 0.8 does not mean 80% accuracy. The comparison assessed the pattern of relative changes, while Doppler ultrasound measured blood velocity in a specific artery, not the overall volume of blood flowing to the brain.

In the second preprint, researchers used time-domain near-infrared spectroscopy, or TD-NIRS. They analyzed 60 sessions involving 44 healthy young men. A mathematical model separated hemoglobin changes into superficial and deep components.

When participants tilted their heads downward, BrainFlow correlated more strongly with the estimated deep signal than with the superficial signal: about 0.91 versus 0.49 when accounting for a time shift. This supports further study of its relationship with cerebral circulation. However, when participants moved from a standing to a lying position, the deep component did not show a statistically convincing advantage.

The deep signal here was calculated rather than measured directly inside the brain. The effects of extracerebral tissue on NIRS are also described in a 2023 systematic review by Nick Eleveld and colleagues. This is a general challenge for optical methods, not a finding specific to Temple.

The company notes that both studies are under peer review. For now, the findings are based on small laboratory samples of healthy people; their applicability to vascular conditions and long-term home use still needs to be established.

What Entropy means and what it has to do with longevity

Temple’s Entropy is a separate proprietary metric. On its official website, the company describes it in terms of how intensely the body works to release heat. The developer also uses Resting Entropy and Entropy Max to calculate a metric called Span.

In thermodynamics, entropy has a precise physical meaning. Applying this concept in an app requires an explanation of what quantity the device estimates, how it calculates the result, and which reference method it has been compared against.

Temple cites a study by Nicolas Brodeur and colleagues, published in the journal Entropy on September 3, 2023. The study used direct and indirect calorimetry and a thermodynamic model to calculate entropy production and outflow in 11 men.

This study did not test the Temple device, the accuracy of its scale, or its ability to predict lifespan. Likewise, BrainFlow’s alignment with other signals says nothing automatically about the reliability of Entropy. Each metric needs to be validated separately.

What validation is needed before using these metrics for health

In the V3 methodological framework published by Jennifer Goldsack and colleagues in npj Digital Medicine, validation of digital measurements is divided into three levels: sensor performance, the validity of the algorithm-derived metric, and its clinical applicability. For Temple, this means several specific tasks.

  • Establish the repeatability of measurements and assess the effects of movement, skin contact, and other conditions of everyday use.

  • Independently compare BrainFlow with methods sensitive to cerebral blood flow, while also monitoring superficial circulation. Conditions in which the skin and brain respond differently would be especially useful.

  • Determine the size of the measurement error and the smallest change the device can reliably detect. Test the results in women, older adults, and patients with relevant conditions.

  • For Entropy, define the measured quantity separately and compare the calculation with an appropriate physiological reference standard.

The next question is whether using the metric helps people make useful health decisions–and whether it might prompt unnecessary or harmful actions. In its response to Reuters, the company itself described the scientific basis for BrainFlow and Entropy as still developing and said that some metrics may eventually require regulatory approval.

For now, these indices should not be used for self-diagnosis, changing prescribed medication, or confirming that blood flow to the brain is normal. For device owners, the key missing information is what change exceeds the measurement error and warrants medical action. Without that, even a convincing-looking graph remains difficult to interpret.

Can BrainFlow be compared across different people?

The studies cited do not establish that such comparisons are reliable. Changes that align within one person do not mean that a higher value in someone else corresponds to better blood flow to the brain.

Is higher BrainFlow better?

There is no basis for that conclusion. Blood flow to the brain is regulated according to physiological needs, and an increase in a dimensionless index is not, by itself, an indicator of a health benefit.

Is a randomized study needed to test Temple’s accuracy?

A randomized study is not necessary for the initial accuracy assessment. First, the device needs to be properly compared with suitable reference methods. A randomized trial may be needed later to determine whether using the device improves treatment or prevention outcomes.

How was this article?

 

Share

Explore more